MAIA Biotechnology

Biotechnology
Founded in 1/1/18
Chicago, Illinois, United States
http://www.maiabiotech.com/
For Profit

About MAIA Biotechnology

MAIA Biotechnology, Inc. is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Our lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: 4293
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 16600000 USD
  • Last Funding: 2400000 USD (Venture - Series Unknown)
  • Funding Status: IPO

Technology Stack

MAIA Biotechnology actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology

Headquarters: Chicago, Illinois, United States

Leadership

Employees

  • Mihail Obrocea - CMO & Head, Clinical Development (LinkedIn)